These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P-glycoprotein (P-gp) drug transporter. Aubets J; Jansat JM; Salva M; Birks VM; Cole RJ; Lewis J; Pitcher A; Hall M Pharmacol Res Perspect; 2019 Dec; 7(6):e00540. PubMed ID: 31832203 [TBL] [Abstract][Full Text] [Related]
10. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537 [TBL] [Abstract][Full Text] [Related]
11. Regulation of proton-coupled folate transporter in retinal Müller cells by the antipsoriatic drug monomethylfumarate. Bozard BR; Chothe PP; Tawfik A; Williams C; Fulzele S; Prasad PD; Martin PM; Ganapathy V; Smith SB Glia; 2012 Mar; 60(3):333-42. PubMed ID: 22072423 [TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacokinetics of anti-psoriatic fumaric acid esters. Litjens NH; van Strijen E; van Gulpen C; Mattie H; van Dissel JT; Thio HB; Nibbering PH BMC Pharmacol; 2004 Oct; 4():22. PubMed ID: 15479475 [TBL] [Abstract][Full Text] [Related]
13. The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist. Tang H; Lu JY; Zheng X; Yang Y; Reagan JD Biochem Biophys Res Commun; 2008 Oct; 375(4):562-5. PubMed ID: 18722346 [TBL] [Abstract][Full Text] [Related]
14. Role of increased production of monocytes TNF-alpha, IL-1beta and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments. Mizutani H; Ohmoto Y; Mizutani T; Murata M; Shimizu M J Dermatol Sci; 1997 Feb; 14(2):145-53. PubMed ID: 9039978 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines. Litjens NH; Nibbering PH; Barrois AJ; Zomerdijk TP; Van Den Oudenrijn AC; Noz KC; Rademaker M; Van De Meide PH; Van Dissel JT; Thio B Br J Dermatol; 2003 Mar; 148(3):444-51. PubMed ID: 12653735 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients. Rostami-Yazdi M; Clement B; Mrowietz U Arch Dermatol Res; 2010 Sep; 302(7):531-8. PubMed ID: 20574745 [TBL] [Abstract][Full Text] [Related]
17. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. Wanidworanun C; Strober W J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695 [TBL] [Abstract][Full Text] [Related]
18. The antipsoriatic activity of IL-10 is rather caused by effects on peripheral blood cells than by a direct effect on human keratinocytes. Seifert M; Sterry W; Effenberger E; Rexin A; Friedrich M; Haeussler-Quade A; Volk HD; Asadullah K Arch Dermatol Res; 2000 Apr; 292(4):164-72. PubMed ID: 10836609 [TBL] [Abstract][Full Text] [Related]
19. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients. Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667 [TBL] [Abstract][Full Text] [Related]
20. Effects of monomethylfumarate on human granulocytes. Nibbering PH; Thio B; Zomerdijk TP; Bezemer AC; Beijersbergen RL; van Furth R J Invest Dermatol; 1993 Jul; 101(1):37-42. PubMed ID: 8392528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]